Kush M Parmar
InvestorManaging Partner at 5AM Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
FoundedEntrada Therapeutics, Inc.
About
Kush Parmar combines a Harvard M.D./Ph.D.-backed technical rigor with a cross‑border US–India perspective, taking hands‑on roles as co‑founder, chair, or senior executive to build globally relevant biotech, including India-focused initiatives.
Invests in
BiotechHealthtechMedical Devices
Experience
- 5AM VenturesManaging Partnercurrent2010 — presentBoston, MA
- ProLynxChairmancurrent2025 — present
- Entrada TherapeuticsChairman Of The Board Of Directorscurrent2016 — present
- EnsomaBoard Membercurrent2019 — presentBoston, Massachusetts, United States
- Immuneel Therapeutics, Ltd.Co-Foundercurrent2019 — presentBangalore, India
- Penn Medicine, University of Pennsylvania Health SystemResearch Council Membercurrent2018 — present
- Princeton UniversityAdvisory Council, Department of Molecular Biologycurrent2015 — presentPrinceton, NJ
- Audentes TherapeuticsBoard Of Directorscurrent2013 — present
- Grace Science FoundationMember, Scientific Advisory Board2014 — 2025www.gracescience.org
- Homology Medicines, Inc.Founding CEO, Chairman2015 — 2023Boston, Massachusetts
- Vor BiopharmaChairman2019 — 2022
- AkouosBoard Of Directors2017 — 2022Greater Boston
- ArvinasBoard of Directors2013 — 2019
- scPharmaceuticalsBoard of Directors2014 — 2018
- Novira TherapeuticsBoard Observer and Acting VP, Strategy and Corporate Development2012 — 2015
- AchaogenBoard Observer2010 — 2014
- Society of Kauffman FellowsKauffman Fellow, Class 162011 — 2013
- Envoy Therapeutics, Inc.Board Observer2010 — 2012
- Cruz Blanca InitiativeFounder, President2000 — 2010
Education
- Harvard Medical SchoolMD2002 — 2010
- Harvard Business SchoolFinance2010
- Massachusetts Institute of TechnologyM.D., HST Program2002 — 2010
- Harvard UniversityPh.D., Biomedical Sciences2004 — 2008
- Princeton UniversityA.B., Molecular Biology1998 — 2002
Skills & more
+6 more
Life SciencesPharmaceutical IndustryPrivate EquityBiotechnologyCellTechnology TransferFrom Kush's professional profile.
Same school
Also attended Harvard Medical School113
+ 107 more
Also attended Massachusetts Institute of Technology849
+ 843 more
Also attended Harvard University1,171
+ 1,165 more
Also attended Princeton University444
+ 438 more
Shared employers
Also worked at ProLynx2
Also worked at Princeton University60
+ 54 more
Also worked at Akouos1
Also worked at Arvinas2
Deals · 4
Rallybio CorpBoard seat
via 5AM Ventures · filed Apr 2024 · $6.6M raise
Ensoma, Inc.Board seat
via 5AM Ventures · filed May 2023 · $129M raise
Entrada Therapeutics, Inc.Board seat
via 5AM Ventures · filed Apr 2021 · $116.2M raise
AkouosBoard seat
via 5AM Ventures · filed Aug 2018 · $50.1M raise
Attribution from SEC filings, press coverage, and firm rosters.

.png)










.jpg)

.png)




















